Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

8.34
BATS BZX Real-Time Price
As of 3:50pm ET
 +0.31 / +3.86%
Today’s Change
5.21
Today|||52-Week Range
22.20
-17.10%
Year-to-Date
Is Advaxis' Stock Now a Bargain?
Jul 15 / MotleyFool.com - Paid Partner Content
 

Today’s Trading

Previous close8.03
Today’s open8.20
Day’s range8.13 - 8.40
Volume34,928
Average volume (3 months)793,543
Market cap$275.8M
Dividend yield--
Data as of 3:50pm ET, 07/27/2016

Growth & Valuation

Earnings growth (last year)-73.20%
Earnings growth (this year)-23.93%
Earnings growth (next 5 years)--
Revenue growth (last year)-100.00%
P/E ratioNM
Price/Sales--
Price/Book2.33

Competitors

 Today’s
change
Today’s
% change
AGTCApplied Genetic Tech...+0.44+2.90%
CRVSCorvus Pharmaceutica...-0.37-2.77%
COLLCollegium Pharmaceut...+0.74+6.20%
CRHMCRH Medical Corp+0.13+3.48%
Data as of 3:52pm ET, 07/27/2016

Financials

Next reporting dateSeptember 12, 2016
EPS forecast (this quarter)-$0.50
Annual revenue (last year)$0.00
Annual profit (last year)-$47.0M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Daniel J. O'Connor
COO, Secretary, Director &
Head-Investor Relations
Gregory T. Mayes
Corporate headquarters
Princeton, New Jersey

Forecasts

Partner Offers

Search for Jobs